The US Food and Drug Administration is planning to hold a public meeting on 14 September to gather input on how its next medical device user fee programme should be framed1. The current legislative authority for the programme ends in September 2012 and new legislation will be required for the FDA to be able to continue collecting user fees from medical device companies...
Please login to read the full article.
